G. Krzentowski

1.2k total citations
27 papers, 817 citations indexed

About

G. Krzentowski is a scholar working on Endocrinology, Diabetes and Metabolism, Cell Biology and Physiology. According to data from OpenAlex, G. Krzentowski has authored 27 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Cell Biology and 8 papers in Physiology. Recurrent topics in G. Krzentowski's work include Muscle metabolism and nutrition (10 papers), Diabetes Management and Research (9 papers) and Adipose Tissue and Metabolism (6 papers). G. Krzentowski is often cited by papers focused on Muscle metabolism and nutrition (10 papers), Diabetes Management and Research (9 papers) and Adipose Tissue and Metabolism (6 papers). G. Krzentowski collaborates with scholars based in Belgium and Germany. G. Krzentowski's co-authors include Pierre J. Lefèbvre, Adelin Albert, F. Mosora, M. Lacroix, A Luyckx, F Pirnay, N. Pallikarakis, Jean‐Claude Daubresse, André Scheen and P Lefèbvre and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

G. Krzentowski

27 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Krzentowski Belgium 15 290 244 234 187 186 27 817
R E Gleason United States 12 275 0.9× 183 0.8× 110 0.5× 130 0.7× 110 0.6× 19 633
Ronald J. Graf United States 11 289 1.0× 193 0.8× 54 0.2× 172 0.9× 96 0.5× 14 589
Yaichiro Yukimura Japan 12 306 1.1× 281 1.2× 49 0.2× 100 0.5× 34 0.2× 19 666
Akinori Kogure Japan 14 105 0.4× 341 1.4× 69 0.3× 27 0.1× 73 0.4× 26 589
K.R.W. Gillon United Kingdom 13 81 0.3× 219 0.9× 148 0.6× 408 2.2× 18 0.1× 19 789
Shigehito Mori Japan 12 128 0.4× 244 1.0× 26 0.1× 280 1.5× 73 0.4× 30 720
Andrej Orszag Canada 18 340 1.2× 332 1.4× 13 0.1× 199 1.1× 142 0.8× 49 1.1k
H. Sasaki Japan 11 218 0.8× 110 0.5× 13 0.1× 203 1.1× 58 0.3× 28 549
Naoyoshi MASAKI Japan 3 142 0.5× 180 0.7× 24 0.1× 189 1.0× 108 0.6× 3 547
Kenichi Kimura Japan 17 67 0.2× 135 0.6× 38 0.2× 205 1.1× 36 0.2× 51 655

Countries citing papers authored by G. Krzentowski

Since Specialization
Citations

This map shows the geographic impact of G. Krzentowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Krzentowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Krzentowski more than expected).

Fields of papers citing papers by G. Krzentowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Krzentowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Krzentowski. The network helps show where G. Krzentowski may publish in the future.

Co-authorship network of co-authors of G. Krzentowski

This figure shows the co-authorship network connecting the top 25 collaborators of G. Krzentowski. A scholar is included among the top collaborators of G. Krzentowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Krzentowski. G. Krzentowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hermans, Michel P., et al.. (2010). Evaluating Benchmarking to Optimize Management of Type 2 Diabetes Patients: The Belgian Data of the Optimise study. Document Server@UHasselt (UHasselt). 1 indexed citations
2.
Krzentowski, G.. (2005). [The role of diabetes associations].. PubMed. 60(5-6). 612–4. 1 indexed citations
3.
Krzentowski, G., et al.. (2004). Un autre regard sur les implications de l’étude DCCT. Annales d Endocrinologie. 65(5). 429–435. 6 indexed citations
4.
Krzentowski, G., et al.. (2003). Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control. Diabetic Medicine. 20(7). 580–585. 26 indexed citations
5.
Weets, Ilse, Jean‐Claude Daubresse, Ivo H. De Leeuw, et al.. (2002). Relation between Disease Phenotype and HLA-DQ Genotype in Diabetic Patients Diagnosed in Early Adulthood. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2597–2605. 21 indexed citations
6.
Kaisaki, Pamela J., Valérie Pouillon, Cyril Gueydan, et al.. (2002). The Gene INPPL1, Encoding the Lipid Phosphatase SHIP2, Is a Candidate for Type 2 Diabetes In Rat and Man. Diabetes. 51(7). 2012–2017. 100 indexed citations
7.
Krzentowski, G., et al.. (2001). Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control. Diabetes Care. 24(7). 1275–1279. 194 indexed citations
8.
Decochez, Katelijn, Jean-Luc Coolens, L. Van Gaal, et al.. (2000). High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.. Diabetes Care. 23(6). 838–844. 95 indexed citations
9.
Daubresse, Jean‐Claude, et al.. (1996). Usefulness of Fluoxetine in Obese Non‐Insulin‐Dependent Diabetics: A Multicenter Study. Obesity Research. 4(4). 391–396. 45 indexed citations
10.
Daubresse, Jean‐Claude, et al.. (1992). Fluoxetine therapy in obese diabetic and glucose intolerant patients.. PubMed. 16 Suppl 4. S63–6. 16 indexed citations
11.
Krzentowski, G., et al.. (1991). [Lack of benefit from the intermittent administration of insulin in treatment using subcutaneous perfusion pump in type 1 diabetes].. PubMed. 17(3). 363–72. 1 indexed citations
12.
Gérard, Jean‐Louis, Bernard Jandrain, F Pirnay, et al.. (1986). Utilization of Oral Sucrose Load During Exercise in Humans: Effect of the α-Glucosidase Inhibitor Acarbose. Diabetes. 35(11). 1294–1301. 10 indexed citations
13.
Lefèbvre, Pierre J., N. Pallikarakis, G. Krzentowski, et al.. (1986). Metabolic availability of carbohydrates ingested during, before, or after muscular exercise. Diabetes/Metabolism Reviews. 1(4). 483–500. 8 indexed citations
14.
Krzentowski, G., Bernard Jandrain, F Pirnay, et al.. (1984). Availability of glucose given orally during exercise. Journal of Applied Physiology. 56(2). 315–320. 25 indexed citations
15.
Krzentowski, G., F Pirnay, A Luyckx, et al.. (1984). Effect of physical training on utilization of a glucose load given orally during exercise. American Journal of Physiology-Endocrinology and Metabolism. 246(5). E412–E417. 23 indexed citations
16.
Scheen, André, G. Krzentowski, Manuel J. Castillo, P. J. Lef�bvre, & A Luyckx. (1983). A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin. Diabetologia. 24(5). 319–25. 8 indexed citations
17.
Krzentowski, G., A J Scheen, Manuel J. Castillo, A Luyckx, & P. J. Lef�bvre. (1983). A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia. 24(5). 314–8. 28 indexed citations
18.
Krzentowski, G., Jean-Michel Crielaard, N. Pallikarakis, et al.. (1982). Fate of exogneous glucose metabolism during exercise of different intensities in humans. Journal of Applied Physiology. 53. 1 indexed citations
19.
Krzentowski, G., F Pirnay, A Luyckx, et al.. (1982). Metabolic adaptations in post‐exercise recovery. Clinical Physiology. 2(4). 277–288. 33 indexed citations
20.
Mosora, F., M. Lacroix, A Luyckx, et al.. (1981). Glucose oxidation in relation to the size of the oral glucose loading dose. Metabolism. 30(12). 1143–1149. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R E Gleason Breakdown of academic impact, for papers by Ronald J. Graf Breakdown of academic impact, for papers by Yaichiro Yukimura Breakdown of academic impact, for papers by Akinori Kogure Breakdown of academic impact, for papers by K.R.W. Gillon Breakdown of academic impact, for papers by Shigehito Mori Breakdown of academic impact, for papers by Andrej Orszag Breakdown of academic impact, for papers by H. Sasaki Breakdown of academic impact, for papers by Naoyoshi MASAKI Breakdown of academic impact, for papers by Kenichi Kimura
Rankless by CCL
2026